Soy affects trabecular microarchitecture and favorably alters select bone-specific gene expressions in a male rat model of osteoporosis

Calcified Tissue International

Volumn 78, Issue 6, 2006, Pages 385-391

  Soung, D Y ^a   Devareddy, L ^a   Khalil, D A ^a   Hooshmand, S ^a   Patade, A ^a   Lucas, E A ^a   Arjmandi, B H ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Isoflavone; Microarchitecture; Northern Blot; Orchidectomy

Indexed keywords

ALKALINE PHOSPHATASE; CASEIN; COLLAGEN TYPE 1; ISOFLAVONE DERIVATIVE; MESSENGER RNA; OSTEOCALCIN; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE STRUCTURE; CONTROLLED STUDY; DIETARY INTAKE; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; EXPERIMENTAL MODEL; FEMUR NECK; LOW DRUG DOSE; MALE; NONHUMAN; ORCHIECTOMY; OSSIFICATION; OSTEOPOROSIS; PRIORITY JOURNAL; RAT; SOYBEAN; TRABECULAR BONE;

ALKALINE PHOSPHATASE; ANIMALS; BONE DENSITY; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMUR; GENE EXPRESSION; ISOFLAVONES; MALE; ORCHIECTOMY; OSTEOCALCIN; OSTEOGENESIS; OSTEOPOROSIS; RATS; RATS, INBRED F344; RNA, MESSENGER; SOYBEAN PROTEINS;

EID: 33746048009     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-005-0069-9     Document Type: Article

References (38)

1. Gehlbach SH, Burge RT, Puleo E, Klar J (2003) Hospital care of osteoporosis-related vertebral fractures. Osteoporos Int 14:53-60
2. Trombetti A, Herrmann F, Hoffmeyer P, Schurch MA, Bonjour JP, Rizzoli R (2002) Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 13:731-737
3. de Laet CE, van der KM, Hofman A, Pols HA (2002) Osteoporosis in men and women: a story about bone mineral density thresholds and hip fracture risk. J Bone Miner Res 17:2231-2236
4. Melton LJ III, Thamer M, Ray NF, Chan JK, Chesnut CH III, Einhorn TA, Johnston CC, Raisz LG, Silverman SL, Siris ES (1997) Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res 12:16-23
5. Gennari L, Merlotti D, Martini G, Gonnelli S, Franci B, Campagna S, Lucani B, Dal Canto N, Valenti R, Gennari C, Nuti R (2003) Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J Clin Endocrinol Metab 88:5327-5333
6. Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F, Duboeuf F, Delmas PD (2001) Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab 86:192-199
7. Otto F, Lubbert M, Stock M (2003) Upstream and downstream targets of RUNX proteins. J Cell Biochem 89:9-18
8. Halleen JM, Raisanen SR, Alatalo SL, Vaananen HK (2003) Potential function for the ROS-generating activity of TRACP. J Bone Miner Res 18:1908-1911
9. Khalil DA, Lucas EA, Smith BJ, Soung DY, Devareddy L, Juma S, Akhter MP, Recker R, Arjmandi BH (2005) Soy isoflavones may protect against orchidectomy-induced bone loss in aged male rats. Calcif Tissue Int 76:56-62
10. Gowen M, Lazner F, Dodds R, Kapadia R, Feild J Tavaria M, Bertoncello I, Drake F, Zavarselk S, Tellis I, Hertzog P, Debouck C, Kola I (1999) Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14:1654-1663
11. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
12. Plant A, Tobias JH (2001) Characterisation of the temporal sequence of osteoblast gene expression during estrogen-induced osteogenesis in female mice. J Cell Biochem 82:683-691
13. Battaglino R, Kim D, Fu J, Vaage B, Fu XY, Stashenko P (2002) c-myc is required for osteoclast differentiation. J Bone Miner Res 17:763-773
14. Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B (2004) Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 15:108-112
15. Orwoll ES, Klein RF (1995) Osteoporosis in men. Endocr Rev 16:87-116
16. Erben RG, Eberle J, Stahr K, Goldberg M (2000) Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study. J Bone Miner Res 15:1085-1098
17. Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, Juma S, Alekel L, Hasler CM, Drum ML, Hollis BW, Kukreja SC (1998) Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 68:1364S-1368S
18. Arjmandi BH, Getlinger MJ, Goyal NV, Alekel L, Hasler CM, Juma S, Drum ML, Hollis BW, Kukreja SC (1998) Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 68:1358S-1363S
19. Kalu DN, Masoro EJ, Yu BP, Hardin RR, Hollis BW (1988) Modulation of age-related hyperparathyroidism and senile bone loss in Fischer rats by soy protein and food restriction. Endocrinology 122:1847-1854
20. Ding M, Odgaard A, Linde F, Hvid I (2002) Age-related variations in the microstructure of human tibial cancellous bone. J Orthop Res 20:615-621
21. Halloran BP, Ferguson VL, Simske SJ, Burghardt A, Venton LL, Majumdar S (2002) Changes in bone structure and mass with advancing age in the male C57BL/6J mouse. J Bone Miner Res 17:1044-1050
22. Einhorn TA (2001) The bone organ system: form and function. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, California
23. Sietsema WK (1995) Animal models of cortical porosity. Bone 17:297S-305S
24. Choi EM, Suh KS, Kim YS, Choue RW, Koo SJ (2001) Soybean ethanol extract increases the function of osteoblastic MC3T3-E1 cells. Phytochemistry 56:733-739
25. Jia TL, Wang HZ, Xie LP, Wang XY, Zhang RQ (2003) Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. Biochem Pharmacol 65:709-715
26. Huang W, Carlsen B, Rudkin G, Berry M, Ishida K, Yamaguchi DT, Miller TA (2004) Osteopontin is a negative regulator of proliferation and differentiation in MC3T3-E1 pre-osteoblastic cells. Bone 34:799-808
27. Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J (2002) Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J Bone Miner Res 17:1486-1497
28. Heim M, Frank O, Kampmann G, Sochocky N, Pennimpede T, Fuchs P, Hunziker W, Weber P, Martin I, Bendik I (2004) The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinoloey 145:848-859
29. Arjmandi BH, Khalil DA, Smith BJ, Lucas EA, Juma S, Payton ME, Wild RA (2003) Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 88:1048-1054
30. Khalil DA, Lucas EA, Juma S, Smith BJ, Payton ME, Arjmandi BH (2002) Soy protein supplementation increases serum insulin-like growth factor-I in young and old men but does not affect markers of bone metabolism. J Nutr 132:2605-2608
31. Sun L, Vitolo M, Passaniti A (2001) Runt-related gene 2 in endothelial cells: inducible expression and specific regulation of cell migration and invasion. Cancer Res 61:4994-5001
32. Vandenput L, Swinnen JV, Van Herck E, Verstuyf A, Boonen S, Bouillon R, Vanderschueren D (2002) The estrogen receptor ligand ICI 182,780 does not impair the bone-sparing effects of testosterone in the young orchidectomized rat model. Calcif Tissue Int 70:170-175
33. Iwamoto J, Takeda T, Katsumata T, Tanaka T, Ichimura S, Toyama Y (2002) Effect of etidronate on bone in orchidectomized and sciatic neurectomized adult rats. Bone 30:360-367
34. Huber DM, Bendixen AC, Pathrose P, Srivastava S, Dienger KM, Shevde NK, Pike JW (2001) Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor. Endocrinology 142:3800-3808
35. 2+ signaling. Biol Pharm Bull 22:805-809
36. Gao YH, Yamaguchi M (2000) Suppressive effect of genistein on rat bone osteoclasts: involvement of protein kinase inhibition and protein tyrosine phosphatase activation. Int J Mol Med 5:261-267
37. Crisafulli A, Altavilla D, Squadrito G, Romeo A, Adamo EB, Marini R, Inferrera MA, Marini H, Bitto A, D'Anna R, Corrado F, Bartolone S, Frisina N, Squadrito F (2004) Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women. J Clin Endocrinol Metab 89:188-192
38. Mathey J, Puel C, Kati-Coulibaly S, Bennetau-Pelissero C, Davicco MJ, Lebecque P, Horcajada MN, Coxam V (2004) Fructooligosaccharides maximize bone-sparing effects of soy isoflavone-enriched diet in the ovariectomized rat. Calcif Tissue Int 75:169-179